Full-Time

Associate Director

TMF Management & Inspection Readiness

Posted on 8/7/2024

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$144k - $180.5kAnnually

+ Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

Hybrid position requiring in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Management
Requirements
  • Bachelor’s degree in the life sciences or related field; Advanced degree preferred.
  • Targeting at least 8 years pharmaceutical industry and/or clinical research organization experience, with at least 4 years TMF experience in a leadership and oversight role.
  • Health Authority inspection experience is required.
  • Thorough understanding of GCP and ICH guidelines; thorough understanding of the drug development process.
  • Knowledge and understanding of the current regulatory requirements (e.g., FDA, EMA, MHRA) in a global environment.
  • Thorough understanding of the CDISC TMF Reference model; direct experience with the TMF Reference Model working group is preferred.
  • eTMF experience required; Veeva Vault eTMF/CTMS experience preferred.
  • Demonstrated problem-solving abilities, with strong attention to detail.
  • Adept at creating and communicating a clear vision among direct reports, effectively aligning resources and motivating stakeholders to achieve goals.
  • Demonstrated analytical abilities and proficient planning and negotiation skills.
  • Strong interpersonal, organizational and workload planning skills along with excellent verbal and written communication skills.
  • Demonstrated success with cross-functional collaboration and managing multiple assignments with timely and accurate output.
  • Demonstrated technical, administrative, and project management capabilities.
  • Ability to travel approximately 25% of the time.
Responsibilities
  • Is responsible for resource planning, including consultants, to support TMF and inspection readiness including TMF management vendor to ensure compliance with GCP and industry standards.
  • Provide leadership and oversight for the Trial Master File (TMF) process, including the TMF related controlled documents/templates, ensuring compliance with regulatory requirements and organizational standards.
  • Review TMF metrics across programs, analyzing TMF performance indicators and identifying trends or deviations from Key Performance Indicators (KPIs).
  • Escalate any TMF metrics falling outside of KPIs to appropriate stakeholders for resolution and corrective action.
  • Serve as a key point of contact for TMF-related inquiries and provide SME guidance to internal stakeholders on TMF processes and requirements.
  • Lead the development and maintenance of comprehensive inspection readiness plans, tools, reference materials, and provide guidance to staff on preparation efforts for health authority inspections.
  • Support Clinical Operations team on all inspection commitments, responses, post-inspection activities and implementation of corrective and preventative actions; provide lessons learned from mock and actual inspections.
  • Assist the liaison between Acadia and regulatory agencies, facilitating communication and information exchange during inspections and providing leadership to staff in inspection preparation and response strategies.
  • Lead and share TMF best practices with internal and external stakeholders, as appropriate.
  • Maintain awareness of industry trends and developments to help define the future strategic direction for TMF and Inspection Readiness.
  • Other responsibilities as required.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these conditions while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
  • Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
  • The rise of personalized medicine aligns with Acadia's targeted therapy approach.

What critics are saying

  • Increased competition in CNS drug market may impact Acadia's market share.
  • Potential clinical trial delays could affect drug approval timelines.
  • Dependence on partnerships poses risks if collaborations face challenges or dissolve.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
  • The company has a strong R&D foundation, developing innovative small molecule drugs.
  • Acadia's strategic partnerships enhance its research capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

INACTIVE